126787-65-3,
3-Indolyl-b-D-galactopyranoside,
3-Indoxyl-beta-D-galactopyranoside,
Indoxyl--D-galactopyranoside,
Indoxyl-beta-D-galactopyranoside,
Indol-3-yl--D-galactopyranoside,
MFCD00083389,
3-INDOLYL B-D-GALACTOPYRANOSIDE,
VA 2914,
(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-(1H-indol-3-yloxy)oxane-3,4,5-triol,
3-Indolyl-b-D-glucopyranoside,
Indoxyl |A-D-galactopyranoside,
Indoxyl beta-D-galactopyranoside,
1H-Indol-3-yl beta-D-galactopyranoside,
AC1MBZN9,
Indol-3-yl-b-D-galactoside,
SCHEMBL153372,
DTXSID50370003,
ZX-AFC003210,
3-indolyl beta-d-galactopyranoside,
3-Indolyl-beta-D-galactopyranoside,
ZINC4282173,
AKOS016844825,
1H-Indole-3-yl beta-D-galactopyranoside,
AJ-50128,
AK135484,
AN-32534,
AX8134684,
FT-0627233,
W0187,
A-8131,
787I653,
I07-395,
(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-(1H-indol-3-yloxy)tetrahydropyran-3,4,5-triol,
(2S,3R,4S,5R,6R)-2-(1H-indol-3-yloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol,
Uroxanthin,
C14H17NO6,
CBD 2914,
CID2733771,
(11b)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione,
487-60-5,